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Abstract
Background: Lipids are an important and highly diverse class of molecules having structural,
energy storage and signaling roles. Modern analytical technologies afford screening of many lipid
molecular species in parallel. One of the biggest challenges of lipidomics is elucidation of important
pathobiological phenomena from the integration of the large amounts of new data becoming
available.
Results: We present computational and informatics approaches to study lipid molecular profiles
in the context of known metabolic pathways and established pathophysiological responses, utilizing
information obtained from modern analytical technologies. In order to facilitate identification of
lipids, we compute the scaffold of theoretically possible lipids based on known lipid building blocks
such as polar head groups and fatty acids. Each compound entry is linked to the available
information on lipid pathways and contains the information that can be utilized for its automated
identification from high-throughput UPLC/MS-based lipidomics experiments. The utility of our
approach is demonstrated by its application to the lipidomic characterization of the fatty liver of
the genetically obese insulin resistant ob/ob mouse model. We investigate the changes of
correlation structure of the lipidome using multivariate analysis, as well as reconstruct the
pathways for specific molecular species of interest using available lipidomic and gene expression
data.
Conclusion: The methodology presented herein facilitates identification and interpretation of
high-throughput lipidomics data. In the context of the ob/ob mouse liver profiling, we have
identified the parallel associations between the elevated triacylglycerol levels and the ceramides, as
well as the putative activated ceramide-synthesis pathways.
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Background
Lipids are a diverse class of biological molecules that play
a central role as structural components of biological mem-
branes, energy reserves, and signaling molecules [1]. They
are broadly defined as hydrophobic or amphipathic small
molecules that may originate entirely or in part by carban-
ion based condensation of thioesters, and/or by carboca-
tion based condensation of isoprene units [2]. Lipids also
contribute to common pathophysiological states such as
fatty liver and lipotoxic induced insulin resistance, Alzhe-
imer's disease, atherosclerosis, and toxic manifestations of
infectious diseases [3,4]. Therefore identification and
characterization of these metabolic networks offers a
unique opportunity to devise therapeutic strategies to pre-
vent or reverse these pathological states.
While lipid-, and metabolome research in general, over
past decades was overshadowed by the progress of
genomics, recent revived and burgeoning interest in lipids
that triggered several new endeavors in lipid research illus-
trates their critical biological importance. Lipidomics as a
field aims at characterization of lipid molecular species
and their biological roles with respect to the expression of
proteins involved in lipid metabolism and function
including gene regulation [5,6].
Several useful public resources exist representing various
aspects of information on lipids, such as LIPID MAPS
[7,8], Lipid Bank [9], CyberLipids [10], and LIPIDAT [11].
The LIPID MAPS consortium introduced a nomenclature
that enables to represent a lipid compound by a unique
12-digit identifier [2]. LIPID MAPS also includes tandem
mass spectrometry (MS/MS) fragment information for
several lipid molecular species.
With the enhanced capabilities of modern MS instru-
ments and interfaces, there has been an increase in devel-
opment of global lipid analytical methods, either using
liquid chromatography mass spectrometry (LC/MS) based
methods focused on sensitive analyses of total lipid
extracts or on specific classes of metabolites [12-15], or
direct MSn scanning driven by data-dependent acquisition
[16-19] without chromatographic separation. Due to the
structural characteristics of lipids their identification from
fragment mass spectra is generally easier than for other
molecular components and today's typical global lipid
profiling analyses allows identifying of several hundred
lipid molecular species in parallel. Informatics strategies
have already been developed which utilize mass spec-
trometry based approaches in combination with database
searches to rapidly identify specific classes of lipids, such
as phospholipids [16] or PUFA-derived lipid mediators
[20]. While much further progress is still needed in the
area of lipid analytics, one of the biggest challenges is elu-
cidation of biological phenomena behind the large
amounts of lipidomics data currently available.
Advances in analytical methods, along with improved
data processing software solutions [21-25], demand
development of comprehensive lipid libraries to allow
system level identification, discovery, and subsequent
study of lipids. Integrative studies combining multi-tissue
lipidomic profiles with other levels of biological informa-
tion such as gene expression and proteomics have been
made possible due to such capabilities [26,27]. Currently
available databanks such as LIPID MAPS offer a necessary
starting point for explorations of the lipidome and a refer-
ence for validation of results. However, in context of high-
throughput lipidomic profiling and systems biology stud-
ies, the currently available online resources face threefold
challenge:
1. Due to high volumes of information available from
high-throughput lipidomics experiments, the database
system has to be efficiently linked to the analytical plat-
form generating the lipid profile data, as well as to chemo-
and bioinformatics system for compound identification
and linking the information to other levels of biological
organization to enable systems approaches.
2. Due to diversity of lipids across different organisms, tis-
sues, and cell types, it is unlikely any one database can
cover all possible lipids. A mechanism is therefore neces-
sary that facilitates identification as well as discovery of
new lipid species in biological systems from available
data.
3. Currently available pathway-level representation of lip-
ids in databases such as KEGG [28] is limited to pathway
representation of generic lipid classes, i.e. including
mainly the head group information, and not including
the fatty acid side chain information. Therefore, these
lipid databases lack the level of detail that is becoming
available by modern LC/MS based approaches.
Additionally, due to common structural features of differ-
ent lipid classes, often regulated by the same enzymes in
class-specific manner, there is a large degree of co-regula-
tion to be expected in cellular, tissue, or biofluid lipid pro-
files. In order to elucidate the changes of the organism
lipidome as a result of interventions, the data analysis and
interpretation therefore needs to balance the analysis of
global lipid pattern changes with the analysis of molecu-
lar species specific pathways.
In this paper we report a bioinformatics strategy for lipid-
omics analysis. We utilize the recently developed nomen-
clature of lipids [2] to generate a diverse scaffold of lipid
compounds represented by the Simplified MolecularBMC Systems Biology 2007, 1:12 http://www.biomedcentral.com/1752-0509/1/12
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Input Line Entry System (SMILES) representation [29,30].
Each compound entry is linked to the available informa-
tion on lipid pathways and contains the information that
can be utilized for automated identification from high-
throughput LC/MS-based lipidomics experiments. We
investigate the changes of correlation structure of the lipi-
dome using multivariate analysis, as well as reconstruct
the pathways for specific molecular instances of interest
using available lipidomic and gene expression data.
We validate our approach by investigating the lipid pro-
files associated with hepatic steatosis observed in ob/ob
mice. Our results indicate that obesity associated hepatic
steatosis involves increased liver deposition of short chain
triacylglycerol species associated with proportional
increase of reactive ceramide lipid species. Of interest, the
contribution of triacylglycerol molecular species is heter-
ogenesous as indicated by the presence of a subset of long
triacylglycerol species that does not contribute to the
development of steatosis. We also provide evidence of
specific dysregulation of ceramide synthesis pathways in




In this paper we primarily focus on studies of glycero-
phospholipids, sphingolipids, glycerolipids, and sterol
esters. The main structural variants among these classes
are variation within one or more fatty acid chains and the
head group (see an example in Figure 1). In order to facil-
itate automated identification of lipids from lipidomics
experiments, we used the structural rules of lipid molecu-
lar species to computationally generate a diverse set of lip-
ids from "seed" fatty acids most likely to occur in living
systems (Additional file 1 lists the seed fatty acids utilized
in this paper). Our current choice of seeds reflects bias
toward the mammalian cells, but the approach is general
enough to afford suitable modifications depending on the
area of interest.
The fatty acid seeds are expressed in terms of Simplified
Molecular Input Line Entry System (SMILES), which is a
human readable linear indexing system of atoms and
bonds, dictated by specific syntax rules [29]. The modular
nature of the lipid structure makes the SMILES representa-
tion very suitable for the task due to ease of algorithmic
manipulation of lipid (sub)structures and their modifica-
tions. While in general multiple SMILES representations
can exist for any given compound, canonical versions that
enable unique SMILES representation are available. We
utilize the Daylight canonical SMILES representation
(Daylight, Chemical information system, Inc.). We gener-
ate a generic SMILES template for different classes of lipids
and apply parsers for varying fatty acid chain lengths in
order to create all possible compounds of that class in the
given window of chosen fatty acid chain length. System-
atic names complying with nomenclature of LIPID MAPS
were generated algorithmically (Additional file 2 lists the
lipid classes generated and their sizes in the database).
Daylight SMILES Toolkit was tailored to get molecular
weights and exact masses of compounds using elemental
masses taken from literature [31].
Our approach is illustrated below using a systematic con-
struction of glycerophospholipids classes as an example:
1. Construct generic SMILES template for glycerophos-
pholipid class. SMILES template showing fatty acid seed
variables at the sn-1 and sn-2 positions and head group at
sn-3 position is:
"C(SMILES for fatty acid seed variable(R1))C(SMILES for
fatty acid seed variable (R2))COP(=O)([O-])O-X)", where
X represents SMILES for relevant part of head groups as
shown in Figure 1.
2. Use corresponding systematic names against fatty acid
seed SMILES to generate names using common name tem-
plate:
"1-name of seed variable R1-2-name of seed variable R2-
sn-glycero-3- name corresponding to X".
3. Convert SMILES into canonical SMILES.
4. From SMILES, obtain molecular formula and calculate
molecular weight.
5. Obtain isotopic distribution of that compound and tai-
lor it to the resolution of mass spectrometer.
The differences in length and degree of unsaturation in
fatty acyl/alkyl chains lead to large diversity within each
lipid class. When matching such database with the exper-
imental lipidomics results, the searches thus inevitably
result in large number of hits, both due to multiple close
matches in mass as well as due to limitations of the ana-
lytical approach. In order to facilitate sifting through the
multiple hits, we set up a heuristic scoring scheme based
on seed fatty acid composition as described in Methods.
Lipidomics data processing and identification
Our lipid profiling platform is based on non-targeted
analysis of total lipid extracts using Ultra Performance
Liquid Chromatography (UPLC) coupled to quadrupole
time of flight mass spectrometry. The platform character-
istics are described in detailed elsewhere [32]. In order to
better understand current limitations of the analytical
strategy, as well as because our computational approachesBMC Systems Biology 2007, 1:12 http://www.biomedcentral.com/1752-0509/1/12
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are adaptable to other platforms, including those using
multiple precursor and neutral loss scanning [16,18], the
analysis and data processing are described here only
briefly.
An overview of the lipidomic data flow is shown in Figure
2. We convert raw mass spectrometer files to netCDF for-
mat to enable data processing with MZmine toolbox
[21,22]. Peak detection and alignment parameters in
MZmine are set based on preliminary investigation of
platform specific characteristics such as peak shapes and
retention time variation. Following the processing, each
peak is characterized by mass-to-charge ratio (m/z) and
retention time (RT) values.
In order to facilitate automated identification of lipids
from peak lists, we compute the scaffold of theoretically
possible lipids. LipidDB is a database of lipids constructed
using SMILES, as described in the previous section. The
internal library contains the platform-specific informa-
tion about the internal standards and the lipid species
identified using UPLC/MS/MS. To ease the identification
of lipids based on the mass spectrometric data, we calcu-
late isotopic distribution for every molecular species in
both databases. The isotopic distribution is based on
observed natural abundance of each element in the chem-
ical formula [31]. Isotopic masses and abundances of
given chemical composition are predicted using Isotope
Pattern Calculator version 1.4 [33]. While the exact iso-
Structures of major glycerophospholipids Figure 1
Structures of major glycerophospholipids. R1, R2 and X are SMILES seed variables at sn-1, sn-2 and sn-3 positions 
respectively. Head groups legend: PA = Phosphate, PPA = Pyrophosphate, PE = Phosphoethanolamine, PC = Phosphocholine, 
PS = Phosphoserine, PG = Phosphoglycerol, and PI = Phosphoinositol.BMC Systems Biology 2007, 1:12 http://www.biomedcentral.com/1752-0509/1/12
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tope patterns are kept in the database, the patterns are cor-
rected for resolution of the mass spectrometer when
matching with spectral data.
The internal library of lipids is searched first to ensure
identification of internal standards and previously identi-
fied lipids. Retention times of these lipids are used as a
constraint in lipid identification. The retention time infor-
mation in part resolves the problem of identification of
fatty acid moieties. The molecular species of the same
class and carbon composition, but of different fatty acid
composition, tend to elute at different times. The fatty
acid composition can thus be determined in separate sam-
ple runs using tandem mass spectrometry (UPLC/MS/MS)
in negative (phospho- or sphingolipids) or positive
(acylglycerols) ion mode. In order not to compromise
peak shapes in chromatographic direction, all reference
UPLC/MS/MS spectra are generated in separate runs,
which are set up so that ions selected for MS/MS analysis
are well separated in elution time. We found the variation
in retention times for the method described to be under
1.25%, as tested for multiple tissue or cell types over an
extended period of time (over 18 months) for multiple
UPLC C18 columns [32], therefore confirming retention
time is a reliable parameter for the purpose of identifica-
tion.
In the database, the redundancy due to varying fatty acid
composition for the same molecular weight can be repre-
sented using the common notation showing total number
of carbons and double bonds. For example, a diacylglyc-
erophosphocholine species GPCho(16:0/
Lipidomic platform data flow Figure 2
Lipidomic platform data flow. Summary of our lipidomic platform data flow from raw peak data to interpretation of spec-
tra involving MZmine based data processing, lipid identification, quantification and multivariate data analysis.BMC Systems Biology 2007, 1:12 http://www.biomedcentral.com/1752-0509/1/12
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20:4(5Z,8Z,11Z,14Z)) (named as 1-hexadecanoyl-2-
(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-
choline using LIPID MAPS nomenclature) could be repre-
sented also as GPCho(36:4). However, GPCho(36:4)
could also represent other molecular species, for example
GPCho(20:4(5Z,8Z,11Z,14Z)/16:0) or
GPCho(18:2(9Z,12Z)/18:2(9Z,12Z)).
Peaks not identified by internal library are searched in Lip-
idDB. Lipid identifications with LipidDB involve match-
ing m/z, comparing RT range (based on knowledge on
lipids from internal library), checking heuristic score and/
or MS/MS. Matching of m/z value is a pre-requisite for
identification. In some cases, isobaric species are distin-
guished based on retention time ranges and MS/MS. Pro-
tonated phosphocholine species are identified at even m/
z and sphingomyelin species are identified at odd m/z val-
ues. We also check if identifications originate from the iso-
topic masses at the same retention time. Ultimately,
identification of isobaric species, if not separated chroma-
tographically, also depends on the mass resolution and
type of the mass spectrometer. Specifically, we have
observed co-fragmentation using UPLC/MS/MS in phos-
phatidylcholines and ethanolamine plasmalogens in a
few instances. In such cases, instruments with MSn capa-
bility and high resolution detectors (i.e., Orbitrap or
FTMS) may be necessary for exact identification.
Reconstruction of lipid molecular pathways
Following lipidomics data processing and identification,
data analysis usually includes exploration of data as well
as of their putative biological meaning. In addition to the
level changes of specific metabolites, which can be ana-
lyzed using univariate statistical approaches, co-regula-
tion of metabolites is also of interest. The
interdependence of metabolites is driven by the underly-
ing biophysical mechanisms such as chemical equilib-
rium, mass conservation, or asymmetric control
distribution [34]. Since the lipids of the same class may be
in part regulated by the same enzymes, high degree of
within-class co-regulation is to be expected. Correlation
network analysis has proved to be a valuable tool for
exploring and visualizing co-regulations in metabolomics
data [26,35,36]. A matrix of correlation coefficients, an
indirect measure of distance between metabolites [37], is
computed using pair-wise correlation between the corre-
sponding concentrations of lipids in a given sample. The
matrix is visualized in the form of metabolite correlation
network based on a certain threshold criteria over correla-
tion coefficient values.
In order to gain insight into the molecular mechanisms
underlying the observed co-regulation (or similarly for de-
regulation in specific context), the clustered lipids need to
be mapped into the known pathways. Kyoto Encyclopedia
of Genes and Genomes (KEGG) [22] has been the main
source of information on metabolic pathways. However,
KEGG lipid pathway representation is generally limited to
generic lipid classes, i.e., including mainly the head-group
information, and not including the fatty acid side-chain
information. As the level of information from MS studies
is specific instance of subclass (e.g., 1-octadecanoyl-2-
dodecanoyl-sn-glycero-3-phosphocholine) and not the
common sub class itself (e.g., 1-acyl-2-acyl-sn-glycero-3-
phosphocholine), a mechanism is necessary to convert
generic enzymatic and pathway information from KEGG
database to a specific instance under study. As we have
implemented LIPID MAPS nomenclature, conversion of
KEGG generic names into LIPID MAPS common subclass
names and in turn to specific instance names allows map-
ping of identified lipids into pathways directly from MS-
based studies with other levels of information.
We solve the limitation of generic lipid pathways by
instantiating KEGG (or related) pathways for specific lipid
molecular species of interest (Figure 3). In practice, our
strategy to represent KEGG pathways involves the follow-
ing steps:
1. Convert generic names of lipids in the KEGG reference
lipid pathway into systematic common subclass names
which enable to convert into systematic name for particu-
lar lipid as per LIPID MAPS consortium.
2. Construct XML schema to represent lipid pathway with
systematic names of lipids and known EC numbers.
3. Generate XML document for a queried lipid.
4. Use megNet pathway visualization tool [38] to display
the correlation network of lipids linked to pathways and
ontologies.
Such approach affords visualization of pathways of inter-
est in the context of observed biological data, including
data from other levels such as microarray experiments.
Presently we have not added additional level of quantita-
tive analysis based on instantiated pathway information,
but this is one of future considerations. One should bear
in mind the complexity of such challenge as lipids are reg-
ulated systemically and their levels reflect complex sys-
temic balance, therefore their pathways generally involve
multiple tissues and complex dynamics [39].
Lipid profiling of liver tissue in an obese mouse model
We illustrate the combined informatics and analytical
approach on the liver of ob/ob mice. The ob/ob is an
obese, insulin resistant mouse model resulting from the
spontaneous mutation of the ob gene encoding the leptin
protein [40]. The ob/ob mouse is commonly studied as aBMC Systems Biology 2007, 1:12 http://www.biomedcentral.com/1752-0509/1/12
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model for early onset of severe obesity, insulin resistance
and fatty liver. Figure 4 shows typical liver tissue images of
ob/ob and wild type (WT) mouse, respectively. Lipid
droplet accumulation is clearly seen in the obese model.
Obesity is associated with deposition of triacylglycerols
(TGs) in the liver tissue (hepatosteatosis). Fatty liver
develops as a result of increased free fatty acid (FFA) avail-
ability in the context of obesity and insulin resistance
associated to increased hepatic glucose production [1].
Elevated hepatic FFA levels, which further lead to
increased esterification into TGs, may result from the
combined effect of increased influx of plasma FFAs,
increased de novo FFAs, and decreased β-oxidation [41].
The following genotypes were used for analysis: Wild Type
(WT) and ob/ob. The study included 12 ob/ob (6 male, 6
female) and 10 WT (7 male, 3 female) mice of 16-week
age. Figure 5 lists the results of ULPC/MS lipidomic profil-
ing for selected molecular species, out of total 192 identi-
fied molecular species. Notable changes are upregulation
in the ob/ob livers of tri- and di-acylglycerol species, dia-
cylphosphoglycerols as well as specific reactive ceramide
species. Sphingomyelins, the substrate for ceramide syn-
thesis, appeared downregulated in the liver of the ob/ob
mice compared to their lean littermates. The increase of
acylglycerols should therefore be considered the hallmark
leading to the development of the fatty liver observed in
the ob/ob mice [42,43].
In order to include the correlation structure of lipidomics
data into the analysis and therefore explore possible asso-
ciations between different lipid molecular species, we
applied the partial least squares discriminant analysis
(PLS/DA) [44,45] using the SIMPLS algorithm to calculate
Lipid pathway instantiation Figure 3
Lipid pathway instantiation. An illustrative example of instantiation of two co-regulated molecular species in the context of 
known lipid pathways. Upregulated species and enzymes (triangles) are in red, downregulated in green, unchanged in black.BMC Systems Biology 2007, 1:12 http://www.biomedcentral.com/1752-0509/1/12
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the model [46]. PLS/DA is a common approach to multi-
variate metabolomics data analysis [47,48]. PLS analysis
maximizes the product of variance matrix of measured
variables (e.g. lipid profile data) and correlation of meas-
ured data with properties of interest (e.g. ob/ob and WT
groups). Venetian blinds cross-validation method [49]
(with 4 splits) and Q2 scores were used to optimize the
model. Two latent variables were included in the model
with the Q2 = 58%, which can be considered as a signifi-
cant model. Figure 6A shows the score plot of the PLS/DA
model, with as expected clear separation between the gen-
otypes.
The loadings in Figure 6B indicated that the observed sep-
aration is largely due to accumulation of acylglycerols in
ob/ob mouse livers. Of interest most of the ceramides
(including the most abundant Cer(d18:1/18:0) and
Cer(d18:1/16:0) species) correlated with the short chain
triacylglycerols, suggesting accumulation of reactive cera-
mide species increase in the liver of the ob/ob mice pro-
portionally to the accumulation of triacylglycerol levels.
Curiously, similar correlation between ceramides and tri-
acylglicerols was lost when considering the pool of long
chain triacylglycerols. Additionally, we observed the sepa-
ration of lipid profiles based upon gender basis. The cor-
relation between triacylglycerols and ceramides is
particularly interesting since reactive ceramide species are
believed to play an important role in development of
obesity associated insulin resistance [50]. Therefore our
results suggest that measurement of triacylglycerol in liver
may be a good indirect indicator of other reactive lipid
species pathogenically relevant for the development of
insulin resistance.
We also investigated linear associations among lipid spe-
cies by generating a correlation network. In the network,
edges between the nodes representing lipid species are
drawn if the Pearson correlation meets the cutoff criterion
(r > 0.75 and p-value < 0.001). The nodes are colored
based on fold change values comparing the mean lipid
levels of obese and WT mice. Interestingly, the network
corresponding to WT mouse liver sample contains almost
double the number of edges (2073) as compared to the
number of edges (1055) in the ob/ob mouse liver sample
network. Selected clusters of co-regulated lipids corre-
sponding to wild type and ob/ob mouse liver samples are
shown in Figure 7. The observed decrease in the number
of correlations among the lipid species under ob/ob con-
dition as compared to WT suggests decreased level of co-
regulation among lipid species in the ob/ob mouse liver
tissue, which can be attributed to ob/ob organ-specific
preferential enrichment of subset of lipids. Confirming
PLS/DA results, association of ceramides and triacylglycer-
ols is also observed using correlation network analysis.
We then selected two lipid species, TG(54:3) and
Cer(d18:1/18:0) from the Figure 7B, and mapped them
into the glycerolipid [51] and sphingolipid [52] reference
pathways, respectively (Figure 8). While the notation
TG(54:3) is redundant as there may be several corre-
sponding lipid molecular species with the same func-
tional group, total number of acyl carbons and double
Wild type and ob/ob mice liver cells Figure 4
Wild type and ob/ob mice liver cells. Liver tissue images of wild type (WT) and ob/ob mice.BMC Systems Biology 2007, 1:12 http://www.biomedcentral.com/1752-0509/1/12
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Selected liver lipid profiles from the ob/ob mouse model Figure 5
Selected liver lipid profiles from the ob/ob mouse model. Array view of the lipid profiles. The changes are relative to 
the median intensity of individual molecular species within the Wild Type group. The p-values were calculated based on two-
sided t-test, conservatively adjusted by a Bonfferoni correction for the total number of 192 identified lipids: *(p < 0.05), **(p < 
0.01), ***(p < 0.001).BMC Systems Biology 2007, 1:12 http://www.biomedcentral.com/1752-0509/1/12
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bonds, we selected one particular instance, TG(18:1/18:1/
18:1), for pathway representation. The Figure 8A shows
how this particular lipid species is located in the enzy-
matic system of the glycerolipid pathway. The other path-
way, sphingolipid pathway, is instantiated from the co-
regulated network with the ceramide lipid species
Cer(d18:1/18:0). We utilize for illustration the only pub-
licly available liver ob/ob mouse gene expression data
from ChipperDB [53], obtained from 2 month old male
mice.
From the sphingolipid pathway map (Figure 8B) two
enzymes linked to the ceramide via metabolic reactions,
one is SGPP1 (Sphingosine-1-phosphate phosphatase 1,
UniprotID Q9JI99), the other GALC (galactosylcerami-
dase, UniprotID P54818) were upregulated in ob/ob.
SGPP1 is involved in de novo ceramide synthesis, while
GALC is involved in release of ceramide from glycosphin-
golipids. Interestingly, sphingomyelin SM(d18:1/18:0) as
the known precursor of ceramide via the sphingomyeli-
nase enzymatic action is downregulated, while the sphin-
gomyelinase level is maintained. Therefore, these results
indicate that both glycolipids and free fatty acids may con-
tribute as a source of the elevated ceramides observed in
the ob/ob fatty liver. The elevated fatty acid flux into the
peripheral tissues is a known factor leading to increased
ceramide synthesis [50]. In contrast, mobilization of gly-
cosphingolipids for the synthesis of ceramide has not yet
been characterized in context of obesity or insulin resist-
ance, although the importance of glycosphingolipids in
regulation of insulin sensitivity has been recognized [54].
This is now clearly one area to be investigated further.
Conclusion
Our lipid informatics strategy greatly facilitated interpre-
tation of ob/ob mouse liver lipidomic profiles which
resulted in identification of several lipid molecular spe-
cies. Notable changes in mean lipid levels comparing
obese and their normal littermates among the identified
lipids included upregulation of tri- and di-acylglycerol
species, diacylphosphoglycerols and specific ceramide
species, and downregulation of sphingomyelins in ob/ob
mice. Correlation network analysis revealed decreased
level of co-regulation among lipid species in the ob/ob
condition reflecting the specific enrichment of subset of
lipids. We observed associations of short and medium
chain triacylglycerols and ceramides, both in ob/ob and
WT mice, although these species were significantly upreg-
ulated in ob/ob mice. The pathway instantiation of spe-
cific lipid molecular species in combination to available
gene expression data revealed that both glycolipids and




The lipid data is stored in a native XML database imple-
mented in Tamino XML Server (Software AG). Each com-
PLS/DA analysis of the ob/ob mouse model Figure 6
PLS/DA analysis of the ob/ob mouse model. (A) Score plot reveals genotype differences, as well as gender specific differ-
ences. (B) Loadings reveal major lipid classes associated with genotype differences.BMC Systems Biology 2007, 1:12 http://www.biomedcentral.com/1752-0509/1/12
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Correlation networks for ob/ob and WT mouse liver lipid profiles Figure 7
Correlation networks for ob/ob and WT mouse liver lipid profiles. Selected co-regulated cluster of lipid molecular 
species, including ceramides and acylglycerols. This network is based on Pearson correlation coefficient, r > 0.75 and statistic 
p-value < 0.001. Colored nodes in red (up regulation), green (down regulation) and black (no change) are based on 1.5-fold 
change cut off on mean value comparisons for ob/ob vs. WT mice. (A) Correlation network for WT mouse liver lipidomic data 
(B) Correlation network for ob/ob mouse liver lipidomic data.BMC Systems Biology 2007, 1:12 http://www.biomedcentral.com/1752-0509/1/12
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Instantiated pathways for Cer(d18:1/18:0) and TG(18:1/18:1/18:1) Figure 8
Instantiated pathways for Cer(d18:1/18:0) and TG(18:1/18:1/18:1). Each node represents either lipid metabolite or 
enzyme or other interconnecting metabolism. Grey color represents metabolites/other metabolism and brown represents 
enzymes. Up and down regulation of corresponding nodes are denoted by red and green colors, respectively. Enzyme names 
are shown only if they are differentially regulated (~1.5 fold change). A) Instantiation of TG(18:1/18:1/18:1) as part of glyceroli-
pid metabolism. (B) Instantiation of Cer(d18:1/18:0) as part of sphingolipid metabolism.BMC Systems Biology 2007, 1:12 http://www.biomedcentral.com/1752-0509/1/12
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pound entry in the database is described by an internal
identifier, scoring information, class, canonical SMILES,
molecular formula, molecular weight and isotopic distri-
bution. Perl scripts were developed to convert the data
into XML documents. Resulting XML documents are
loaded using mass-loading tool of the Tamino database.
In the course of implementing the above steps we made
use of XMLSPY software (Altova, Inc.) and Tamino
Schema Editor Software (Software AG) for the construc-
tion and validation of logical and physical schemas,
respectively.
Heuristic lipid database scoring
In order to facilitate database searches, an assigned scor-
ing value for each compound in the database is computed
from scoring values of seed fatty acid chains from which
that compound is formed. Common factors considered
while assigning the scoring to seed fatty acid chains are
natural abundance of the fatty acid and odd/even number
of carbon atoms present in a fatty acid chain. In addition,
different type of bonding (e.g. linked via ether bonds) of
fatty acids to glycerol back bone carbon gets different
score. The lesser the score the more likely the compound
is found in the nature. The total score of a lipid is then a
product of all fatty acid scores. Random score S of any
lipid compound with one or more fatty acid chains whose
score variables Vi (at Sn1 position), Vj (at Sn2 position)
and Vk(at Sn3 position) is obtained as follows
Animal model background information
Animals were housed at a density of four animals per cage
in a temperature-controlled room (20–22fC) with 12-h
light/dark cycles. Food and water were available ad libi-
tum. All animal protocols used in this study were
approved by the UK Home Office and the University of
Cambridge.
The following genotypes were used for analysis: WT (Lep
+/Lep +) and ob/ob (Lep ob/Lep ob). The study included
12 ob/ob (6 male, 6 female) and 10 WT (7 male, 3
female) mice of 16-week age. Genotyping for the point
mutation in the ob gene was performed by PCR using
standard protocols.
For light microscopy analysis, liver tissues were carefully
dissected and fixed in 10% formalin. Tissue was embed-
ded in paraffin and sectioned using a standard microtome
(Leica RM2125RT, Leica, UK). Sections were stained with
hematoxylin and eosin (H&E) using standard protocols.
Lipidomic analysis
An aliquot of 20 µl of an internal standard mixture, 50 µl
of 0.15 M sodium chloride and of chloroform: methanol
(2:1) (200 µl) was added to the weighed (20–30 mg) tis-
sue sample. The standard mixture contains the following
lipids: GPCho(17:0/17:0) (10 µg/ml), GPEtn(17:0/17:0)
(90  µ/ml), GPCho(17:0/0:0) (320 µg/ml), Cer(d18:1/
17:0) (90 µg/ml) and TG(17:0/17:0/17:0) (100 µg/ml).
The sample was homogenized and vortexed (2 min for
liver or 15 sec for islets)) and after 1 hour for liver or 20
min for islets standing centrifuged at 10000 RPM for 3
min. From the separated lower phase, an aliquot was
mixed with 10 µl of a labeled standard mixture (10 µg/ml
GPCho(16:0/0:0-D3), GPCho(16:0/16:0-D6) and
TG(16:0/16:0/16:0-13C3) and 0.5–1.0 µl injection was
used for LC/MS analysis.
Total lipid extracts were analysed on a Waters Q-Tof Pre-
mier mass spectrometer combined with an Acquity Ultra
Performance LC™ (UPLC). The column, which was kept at
50°C, was an Acquity UPLC™ BEH C18 10 × 50 mm with
1.7  µm particles. The binary solvent system (flow rate
0.200 ml/min) included A. water (1% 1 M NH4Ac, 0.1%
HCOOH) and B. LC/MS grade (Rathburn) acetonitrile/
isopropanol (5:2, 1% 1 M NH4Ac, 0.1% HCOOH). The
gradient started from 65% A/35% B, reached 100% B in 6
min and remained there for the next 7 min. The total run
time per sample including a 5 min re-equilibration step
was 18 min. The temperature of the sample organizer was
set at 10°C.
Mass spectrometry was carried out on Q-Tof Premier
(Waters, Inc.) run in ESI+ mode. The data was collected
over the mass range of m/z 300–1200 with a scan dura-
tion of 0.2 sec. The source temperature was set at 120°C
and nitrogen was used as desolvation gas (800 L/h) at
250°C. The voltages of the sampling cone and capillary
were 39 V and 3.2 kV, respectively. Reserpine (50 µg/L)
was used as the lock spray reference compound (5 µl/min;
10 sec scan frequency).
Lipid identification was performed using tandem mass
spectrometry in negative and positive ion mode, as
recently described [32].
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